Molecule Name |
DB09517
|
DrugBank Groups |
Approved
|
Cluster No |
335
|
Smiles |
O2(C(OC1(OC(CO)C(C1O)O)(CO))C(O)C(O)C(C2CO)O)
|
Download |
mol2, pdbqt
|
TPSA |
189,53
|
Non-H Atoms |
23
|
Non-C/H Atoms |
11
|
Metal-Atoms |
0
|
Electronegative Atoms |
11
|
Stereo Centers |
9
|
Rotatable Bonds |
5
|
Rings Closures |
2
|
Small Rings |
2
|
Aromatic Rings |
0
|
Aromatic Atoms |
0
|
sp3-Atoms |
23
|
Symmetric atoms |
0
|
cLogS |
0,682
|
MW |
342,296
|
cLogP |
-4,6102
|
HBA |
11
|
HBD |
8
|
Ro5 violations |
2
|
Druglikeness |
-6,8467
|
DrugScore |
0,280167027545366
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
high
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA-
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
0,6858
|
Caco-2 Permeability 2 |
-0,6117
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity (pLC50, mg/L) |
2,4996
|
Tetrahymena Pyriformis Toxicity |
Low TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
-0,4984
|
Honey Bee Toxicity |
High HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
IV
|
Rat Acute Toxicity (LD50, mol/kg) |
1,0936
|
Carcinogenicity (Three-class) |
Non-required
|